Skip to main content
. 2019 May 29;18(8 Suppl 1):S141–S152. doi: 10.1074/mcp.TIR118.001263

Table III. Enrichment results from a pan-cancer survival analysis.

Cancer type Number of enriched pathways, upregulated Number of enriched pathways after set cover, upregulated Number of enriched pathways, downregulated Number of enriched pathways after set cover, downregulated
Bladder 45 43 7 7
Breast 0 0 16 16
Colorectal 0 0 22 20
Kidney 15 14 11 11
Leukemia 29 24 0 0
Lung 39 34 1 1
Endometrial 1 1 5 5